Legend Biotech Corporation Board of Directors

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.

Deborah Wong

Deborah Wong

Executive Director of Strategic Marketing & Corporate Communications

Mr. Doug Wallace

Mr. Doug Wallace

Vice President of Global Operations

Mr. Tim Roberts

Mr. Tim Roberts

Global Compliance Officer

Ms. Elaine Qian

Ms. Elaine Qian

VP & Global Head of Human Resources

Dr. Guowei Fang Ph.D.

Dr. Guowei Fang Ph.D.

President of Research & Development

Ms. Jessie Yeung M.B.A.

Ms. Jessie Yeung M.B.A.

Interim CFO, Principal Financial Officer & Principal Accounting Officer

Ms. Joanne Choi

Ms. Joanne Choi

Senior Manager of Investor Relations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.